| Price | 6.80 |
| Price Change Today | -$0.01 (-0.15%) |
| P&P rating | ![]() |
| Zacks Rank | 3 - HOLD |
| Open Price | $6.79 |
| Previous Close | $6.81 |
| Daily Range | $6.73 - $6.97 |
| 52-Week Range | $1.18 - $9.07 |
| Volume | 874,848 |
| Threshold is focused on the discovery, development, and commercialization of small molecule therapeutics based on Metabolic Targeting. This approach targets abnormal glucose metabolism - a fundamental property of most solid tumors and other diseases. The company's initial focus is the treatment of cancer and benign prostatic hyperplasia, a disease characterized by overgrowth of the prostate. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment